Role of lipoprotein-associated phospholipase A2 in atherosclerosis

Shahar Lavi, Joerg Herrmann, Ronit Lavi, Joseph P. McConnell, Lilach O. Lerman, Amir Lerman

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a biomarker that can be used to assess the risk for cardiovascular disease and events. In addition to being a useful marker of a risk factor, several studies suggest that Lp-PLA2 has a pathophysiologic role in the atherosclerotic disease process. In this article we review this aspect and its therapeutic implications.

Original languageEnglish (US)
Pages (from-to)230-235
Number of pages6
JournalCurrent atherosclerosis reports
Issue number3
StatePublished - Jun 2008

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Role of lipoprotein-associated phospholipase A2 in atherosclerosis'. Together they form a unique fingerprint.

Cite this